HiLIFE is seeking a Director of the Institute for Molecular Medicine Finland FIMM. FIMM is an international research institute at the forefront of molecular medicine research and with the mission to advance new fundamental understanding of the molecular, cellular and etiological basis of human diseases. FIMM promotes translational research and the adoption of personalised medicine in health care and integrates research with cutting-edge technology platforms. Internationally, FIMM is a partner of the Nordic EMBL Partnership for Molecular Medicine, with three other Nordic research centers and the European Molecular Biology Laboratory (EMBL). FIMM is a member of the international EU-LIFE network comprising thirteen elite biomedical research institutes from Europe. FIMM has an internationally diverse staff of 230 and locally it collaborates with Helsinki University Hospital and National Institute for Health and Welfare THL.
Translational, team-oriented research in scientific grand challenges is focused on the impact of genome information from the Finnish population in personalized health and medicine, individualized cancer medicine, and digital diagnostics for precision medicine. The areas of interest of the 18 research groups in cancer, cardiovascular disease, immune disorders, and neurological and psychiatric diseases provide an opportunity to align FIMM research on large and complex issues and draw researchers, technology experts and clinical collaborators together to achieve common goals through collaboration.